Position in ALKS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,450,288
+$6,280,426 QoQ
Shares Held
199,433
+69.1% QoQ
Ownership
0.119%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#90
of 424 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Derivatives in ALKS
reported options exposure · as of Jun 30, 2025CallValue
$4,291,500
CallShares
150,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $472,275,691 across 58 Drug Manufacturers - Specialty & Generic names. ALKS ranks #13 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,809,278 | $130,014,715 | |
| 2 | HLN |
Haleon plc
|
4,924,330 | $45,943,997 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
253,026 | $42,644,999 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
74,303 | $40,259,592 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
976,361 | $24,028,242 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
559,389 | $19,394,014 | |
| 7 | VTRS |
Viatris Inc
|
1,175,495 | $18,666,859 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,150,820 | $18,447,643 |
All Filings in ALKS
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,450,288 | 199,433 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,169,862 | 117,926 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $6,518,975 | 232,987 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,978,570 | 132,619 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,291,500 | 150,000 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $3,497,800 | 122,258 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,301,899 | 99,997 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,704,013 | 94,020 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,932,456 | 69,041 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,750,936 | 72,653 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,893,139 | 69,935 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,971,591 | 71,074 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,400,500 | 50,000 | Put | Defined | 2023-11-13 | |
| 2023-09-30 | $3,442,175 | 122,891 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,347,411 | 138,895 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $2,792,527 | 99,061 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $674,884 | 25,828 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $703,325 | 31,497 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,004,309 | 33,713 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,514,636 | 171,594 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,769,251 | 205,041 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,401,696 | 304,854 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $26,314,911 | 1,073,202 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $10,119,925 | 541,752 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $5,662,905 | 283,855 | Shares | Defined | 2021-02-09 | |
| 2020-06-30 | $1,559,960 | 80,369 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,170,787 | 81,192 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||